Gestational diabetes and health outcomes for mothers and babies
Official title: Understanding the Effects of Gestational Diabetes on Mother and Baby
Run by Medical University of Graz · NCT07459907 · Data updated 2026-11-12
This project will follow pregnant women with gestational diabetes to see how the condition affects mothers and their babies during pregnancy, delivery, and early postpartum.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years and up |
| Sex | Women only |
| Enrollment | 400 (estimated) |
| Sponsor | Medical University of Graz Academic / other |
| Locations | 1 site (Graz) |
| Status | Recruiting |
| Started | June 15, 2025 |
| Main results expected | June 2030 |
| Study ends | June 2035 |
| Registry record updated | April 13, 2026 |
| Trial ID | NCT07459907 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Pregnant women aged 18 years or older with an ongoing pregnancy before 32 weeks and a positive 75 g oral glucose tolerance test are ideal candidates.
✕Probably not a fit
Women diagnosed after the 32nd gestational week, pregnancies with major fetal anomalies, or those unwilling to attend study visits or provide samples are unlikely to benefit from participation.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This prospective, single-center observational cohort will recruit pregnant women diagnosed with gestational diabetes after a positive 75 g oral glucose tolerance test, typically between gestational weeks 24 and 28. Participants will attend two study visits during pregnancy, provide clinical samples at delivery, and complete a postpartum visit 8–12 weeks after birth, with clinical data, physical measurements, questionnaires, and biological samples collected from mothers and infants. Approximately 100 women will be enrolled per year at the Department of Obstetrics and Gynecology of the Medical University of Graz, and women with major fetal anomalies or diagnosis after 32 weeks are excluded. The collected data and biosamples are intended for comprehensive phenotyping to help define mechanisms and early-life outcomes associated with gestational diabetes.
Why it matters
Potential benefit: If successful, the project could improve understanding of how gestational diabetes affects short- and long-term health and inform better prevention or follow-up strategies for mothers and children.
How similar studies have gone: Other longitudinal gestational diabetes cohorts have provided useful insights into maternal and offspring cardiometabolic risk, so this approach is established though mechanisms remain incompletely understood.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * ongoing pregnancy prior to the 32nd gestational week and a positive GDM screening Exclusion Criteria: * gestational age 32nd gestational week * fetal genetic anomalies /malformation
Where it's running
-
Department of Obstetrics and Gynecology, Medical University of Graz
Graz, Austria Recruiting
Study contacts
- Principal investigator: Christina Stern, Dr. med. — Medical University of Graz
- Study coordinator: Evelyn Jantscher-Krenn, PhD
- Email: evelyn.jantscher-krenn@medunigraz.at
- Phone: +43 316 385 80076
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Natural cervical ripening to delay pharmacological induction of labor
This pilot study tests whether nipple stimulation and membrane sweeping can help some pregnant people go into labor on their own without needing drugs.
-
Maternal insulin and fat metabolism in pregnancies at risk for preeclampsia and gestational diabetes
This project will try to see if insulin resistance and how the body burns fats early in pregnancy predict later preeclampsia or gestational diabetes in people at higher risk.
-
How the placenta affects maternal and fetal health
This project will test whether tiny particles released by the placenta differ in pregnancies with pre-eclampsia, gestational diabetes, or fetal growth restriction compared with healthy pregnancies and non-pregnant women.
-
Pilot testing daily fermented poi to improve the maternal microbiome and lower gestational diabetes risk
This pilot will test whether eating one pound of fermented poi daily for four weeks can change the maternal microbiome and lower gestational diabetes risk for pregnant people in mid-pregnancy.
-
Pregnant Women Living with HIV on Bictegravir/Emtricitabine/Tenofovir Alafenamide
This study looks at how B/F/TAF is used in pregnant women with HIV and whether it helps maintain viral suppression from before conception through delivery.
-
Pelvic Floor Training and a Modified Lumbopelvic Belt for Symphysis Pubis Pain in Pregnancy
This study tests whether pelvic floor muscle training plus a modified lumbopelvic belt can reduce pain and improve function for pregnant women with symphysis pubis pain.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.